vs

Side-by-side financial comparison of Cytosorbents Corp (CTSO) and PROVIDENT FINANCIAL HOLDINGS INC (PROV). Click either name above to swap in a different company.

PROVIDENT FINANCIAL HOLDINGS INC is the larger business by last-quarter revenue ($9.8M vs $9.2M, roughly 1.1× Cytosorbents Corp). PROVIDENT FINANCIAL HOLDINGS INC runs the higher net margin — 14.6% vs -59.5%, a 74.1% gap on every dollar of revenue. On growth, PROVIDENT FINANCIAL HOLDINGS INC posted the faster year-over-year revenue change (2.5% vs 0.9%). PROVIDENT FINANCIAL HOLDINGS INC produced more free cash flow last quarter ($1.0M vs $-4.9M). Over the past eight quarters, PROVIDENT FINANCIAL HOLDINGS INC's revenue compounded faster (2.3% CAGR vs 1.3%).

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

Provident Financial Holdings Inc is a bank holding company operating through its subsidiary Provident Savings Bank. It offers retail and commercial banking services including deposit products, mortgage loans, consumer lending and small business financing for local communities across California.

CTSO vs PROV — Head-to-Head

Bigger by revenue
PROV
PROV
1.1× larger
PROV
$9.8M
$9.2M
CTSO
Growing faster (revenue YoY)
PROV
PROV
+1.6% gap
PROV
2.5%
0.9%
CTSO
Higher net margin
PROV
PROV
74.1% more per $
PROV
14.6%
-59.5%
CTSO
More free cash flow
PROV
PROV
$6.0M more FCF
PROV
$1.0M
$-4.9M
CTSO
Faster 2-yr revenue CAGR
PROV
PROV
Annualised
PROV
2.3%
1.3%
CTSO

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CTSO
CTSO
PROV
PROV
Revenue
$9.2M
$9.8M
Net Profit
$-5.5M
$1.4M
Gross Margin
73.7%
Operating Margin
-47.5%
20.8%
Net Margin
-59.5%
14.6%
Revenue YoY
0.9%
2.5%
Net Profit YoY
27.4%
64.7%
EPS (diluted)
$-0.09
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTSO
CTSO
PROV
PROV
Q4 25
$9.2M
$9.8M
Q3 25
$9.5M
$9.7M
Q2 25
$9.6M
$9.8M
Q1 25
$8.7M
$10.1M
Q4 24
$9.2M
$9.6M
Q3 24
$8.6M
$9.5M
Q2 24
$8.8M
$9.9M
Q1 24
$9.0M
$9.4M
Net Profit
CTSO
CTSO
PROV
PROV
Q4 25
$-5.5M
$1.4M
Q3 25
$-3.2M
$1.7M
Q2 25
$1.9M
$1.6M
Q1 25
$-1.5M
$1.9M
Q4 24
$-7.6M
$872.0K
Q3 24
$-2.8M
$1.9M
Q2 24
$-4.3M
$2.0M
Q1 24
$-6.1M
$1.5M
Gross Margin
CTSO
CTSO
PROV
PROV
Q4 25
73.7%
Q3 25
70.3%
Q2 25
70.9%
Q1 25
71.1%
Q4 24
68.4%
Q3 24
61.0%
Q2 24
73.5%
Q1 24
76.5%
Operating Margin
CTSO
CTSO
PROV
PROV
Q4 25
-47.5%
20.8%
Q3 25
-30.2%
28.1%
Q2 25
-37.6%
23.6%
Q1 25
-44.5%
26.2%
Q4 24
-37.1%
12.7%
Q3 24
-56.1%
28.3%
Q2 24
-40.4%
27.8%
Q1 24
-51.8%
22.5%
Net Margin
CTSO
CTSO
PROV
PROV
Q4 25
-59.5%
14.6%
Q3 25
-33.4%
17.3%
Q2 25
20.2%
16.7%
Q1 25
-16.9%
18.4%
Q4 24
-82.7%
9.1%
Q3 24
-32.1%
20.0%
Q2 24
-48.6%
19.7%
Q1 24
-67.7%
15.9%
EPS (diluted)
CTSO
CTSO
PROV
PROV
Q4 25
$-0.09
$0.22
Q3 25
$-0.05
$0.25
Q2 25
$0.03
$0.24
Q1 25
$-0.02
$0.28
Q4 24
$-0.14
$0.13
Q3 24
$-0.05
$0.28
Q2 24
$-0.08
$0.28
Q1 24
$-0.11
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTSO
CTSO
PROV
PROV
Cash + ST InvestmentsLiquidity on hand
$6.2M
$54.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.9M
$127.5M
Total Assets
$44.2M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTSO
CTSO
PROV
PROV
Q4 25
$6.2M
$54.4M
Q3 25
$7.5M
$49.4M
Q2 25
$10.2M
$53.1M
Q1 25
$11.6M
$50.9M
Q4 24
$3.3M
$45.5M
Q3 24
$5.7M
$48.2M
Q2 24
$8.5M
$51.4M
Q1 24
$8.6M
$51.7M
Total Debt
CTSO
CTSO
PROV
PROV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$13.8M
Q2 24
$13.7M
Q1 24
$4.4M
Stockholders' Equity
CTSO
CTSO
PROV
PROV
Q4 25
$5.9M
$127.5M
Q3 25
$9.0M
$128.4M
Q2 25
$11.6M
$128.5M
Q1 25
$14.5M
$128.9M
Q4 24
$11.1M
$128.6M
Q3 24
$13.4M
$129.6M
Q2 24
$17.4M
$129.9M
Q1 24
$19.6M
$129.5M
Total Assets
CTSO
CTSO
PROV
PROV
Q4 25
$44.2M
$1.2B
Q3 25
$45.8M
$1.2B
Q2 25
$48.0M
$1.2B
Q1 25
$50.8M
$1.3B
Q4 24
$47.4M
$1.3B
Q3 24
$47.8M
$1.3B
Q2 24
$53.4M
$1.3B
Q1 24
$47.1M
$1.3B
Debt / Equity
CTSO
CTSO
PROV
PROV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.03×
Q2 24
0.78×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTSO
CTSO
PROV
PROV
Operating Cash FlowLast quarter
$-4.8M
$1.2M
Free Cash FlowOCF − Capex
$-4.9M
$1.0M
FCF MarginFCF / Revenue
-53.4%
10.5%
Capex IntensityCapex / Revenue
1.2%
1.9%
Cash ConversionOCF / Net Profit
0.85×
TTM Free Cash FlowTrailing 4 quarters
$-12.5M
$14.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTSO
CTSO
PROV
PROV
Q4 25
$-4.8M
$1.2M
Q3 25
$-2.6M
$2.5M
Q2 25
$-1.5M
$8.7M
Q1 25
$-3.5M
$3.3M
Q4 24
$-2.3M
$324.0K
Q3 24
$-2.5M
$2.6M
Q2 24
$-4.8M
$5.7M
Q1 24
$-4.8M
$3.0M
Free Cash Flow
CTSO
CTSO
PROV
PROV
Q4 25
$-4.9M
$1.0M
Q3 25
$-2.6M
$2.5M
Q2 25
$-1.5M
$8.2M
Q1 25
$-3.5M
$3.3M
Q4 24
$-2.4M
$307.0K
Q3 24
$-2.6M
$2.4M
Q2 24
$-4.8M
$4.1M
Q1 24
$-4.9M
$2.6M
FCF Margin
CTSO
CTSO
PROV
PROV
Q4 25
-53.4%
10.5%
Q3 25
-27.3%
25.2%
Q2 25
-16.1%
83.5%
Q1 25
-39.7%
32.5%
Q4 24
-26.3%
3.2%
Q3 24
-30.4%
25.1%
Q2 24
-54.4%
41.3%
Q1 24
-54.2%
27.5%
Capex Intensity
CTSO
CTSO
PROV
PROV
Q4 25
1.2%
1.9%
Q3 25
0.2%
0.5%
Q2 25
0.4%
5.4%
Q1 25
0.0%
0.3%
Q4 24
0.8%
0.2%
Q3 24
1.8%
1.8%
Q2 24
0.2%
16.0%
Q1 24
0.5%
4.2%
Cash Conversion
CTSO
CTSO
PROV
PROV
Q4 25
0.85×
Q3 25
1.48×
Q2 25
-0.78×
5.34×
Q1 25
1.79×
Q4 24
0.37×
Q3 24
1.35×
Q2 24
2.91×
Q1 24
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTSO
CTSO

Direct$5.1M55%
Distributors And Strategic Partners$4.2M45%

PROV
PROV

Segment breakdown not available.

Related Comparisons